- Home
- WORX vs INM Comparison
WORX vs INM Comparison
Compare WORX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- INM
- Stock Information
- Founded
- WORX N/A
- INM 1981
- Country
- WORX United States
- INM Canada
- Employees
- WORX N/A
- INM N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- INM Health Care
- Exchange
- WORX Nasdaq
- INM Nasdaq
- Market Cap
- WORX 3.4M
- INM 3.4M
- IPO Year
- WORX N/A
- INM N/A
- Fundamental
- Price
- WORX $1.80
- INM $4.95
- Analyst Decision
- WORX
- INM
- Analyst Count
- WORX 0
- INM 0
- Target Price
- WORX N/A
- INM N/A
- AVG Volume (30 Days)
- WORX 57.7K
- INM 26.6K
- Earning Date
- WORX 11-14-2024
- INM 02-11-2025
- Dividend Yield
- WORX N/A
- INM N/A
- EPS Growth
- WORX N/A
- INM N/A
- EPS
- WORX N/A
- INM N/A
- Revenue
- WORX $3,224,146.00
- INM $4,960,506.00
- Revenue This Year
- WORX N/A
- INM N/A
- Revenue Next Year
- WORX N/A
- INM N/A
- P/E Ratio
- WORX N/A
- INM N/A
- Revenue Growth
- WORX N/A
- INM 5.17
- 52 Week Low
- WORX $0.75
- INM $2.42
- 52 Week High
- WORX $4.44
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- WORX 52.47
- INM 55.90
- Support Level
- WORX $1.66
- INM $4.07
- Resistance Level
- WORX $1.88
- INM $5.41
- Average True Range (ATR)
- WORX 0.18
- INM 0.39
- MACD
- WORX -0.00
- INM 0.01
- Stochastic Oscillator
- WORX 48.96
- INM 67.83
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.